amonafide has been researched along with Glial Cell Tumors in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cai, S; Cai, Y; Chai, Y; Fang, G; Lei, Y; Li, M; Mei, Z; Qin, C; Shen, L; Wu, J; Xiong, N; Xu, D; Yang, Z; Zhou, J | 1 |
Buckner, JC; Burch, PA; Cascino, TL; Gallagher, JG; Goldberg, RM; Levitt, R; Morton, RF; O'Fallon, JR; Scheithauer, BW; Westberg, MW | 1 |
1 trial(s) available for amonafide and Glial Cell Tumors
Article | Year |
---|---|
Phase II study of amonafide in patients with recurrent glioma.
Topics: Adenine; Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Female; Glioma; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Nervous System Diseases; Oligodendroglioma; Organophosphonates; Recurrence; Tomography, X-Ray Computed; Treatment Outcome | 1995 |
1 other study(ies) available for amonafide and Glial Cell Tumors
Article | Year |
---|---|
Novel prognostic features and personalized treatment strategies for mitochondria-related genes in glioma patients.
Topics: DNA, Mitochondrial; Glioma; Humans; Mitochondria; Molecular Docking Simulation; Precision Medicine; Prognosis | 2023 |